We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Alnylam Receives Notice of Allowance from USPTO

Allowed claims of Manoharan '478 application cover GalNAc-conjugates independent of length, sequence, and disease target.
News

Cypher Genomics, Illumina Enter Biomarker Agreement

Co-promotion agreement to facilitate genomic biomarker discovery.
News

QIAGEN Licenses Blood Cancer Biomarkers

Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including NGS gene panels, for blood cancers.
News

Mass Spec-Based Metabolomics Workflows to Evaluate Plant Immunity

This article reviews metabolomics studies used to evaluate plant immunity with an emphasis on mass spectrometry in its many forms.
News

Horizon and OPDC Sign Collaboration Agreement

Horizon CombinatoRx to perform in-vitro cell line screening of OPDC clinical stage development candidates.
News

Tute Genomics Biomarker Discovery Platform to Support BYU Efforts

Brigham Young University to advance Alzheimer’s disease genetics research.
News

Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold

All other clinical development programs on track.
News

Schizophrenia’s Genetic Skyline Rising

Suspect common variants soar from 30 to 108 - NIH-funded study.
News

Illumina's HiSeq X Ten Sequencing Technology for Population Studies

Next-generation sequencing technologies to be implemented at new High-Throughput Genomics Center for the MENA region.
News

ChIP Sequencing Kit for Next Generation Sequencing

The assay kit from Porvair Sciences extends the benefits of their proprietary Chromatrap® solid state ChIP technology.
Advertisement